entertainment -WSS

entertainment

author：leisure time 2025-10-02 22:24:25 - browse：45754

Illustration of a hospital with stacks of dollar bills on top – private equity coverage from STAT — Adobe

Private equity firms are rapidly buying their way into the U.S. health care system, and as they do, new research finds they tend to increase costs and may also harm quality.

A new BMJ systematic review rounded up 55 studies on the effects of private equity buyouts in health care globally to flesh out an overarching conclusion. The team of researchers found that private equity ownership generally means higher costs for patients, insurance companies, and government programs. The effects on quality were mixed, with more evidence showing that such financial investors degrade quality.

“This is really the first widespread snapshot of what the impacts of all these developments are,” said Alexander Borsa, a study author and doctoral candidate at Columbia University.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Medicaid, Medicare dual

WSS

Was Amgen transparent enough on FDA's concern on cancer drug?

Sana to lay off nearly a third of staff, de

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Stroke deaths set to near 10 million globally by 2050

FDA advisers vote against ALS treatment from BrainStorm

Inequities make cancer less preventable for women: report

hotspot

entertainment

entertainment

Affirmative action in medical school literally saved lives

Biogen shutters digital health group, ends Apple study, in cost cutting move

How to save PrEP access — and even expand it

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Medicare details structure of new drug price negotiation program

FDA advisers vote against ALS treatment from BrainStorm

Trump demands the U.S. pay no more for drugs than other countries … again

Liquid biopsy for lung cancer is launched by Delfi

Apple is now the first public company to be valued at $3 trillion

A Q&A with the global head of Boehringer Ingelheim's innovation unit

hotspot

Senate panel eyes new effort on drug shortages

FDA advisers vote against ALS treatment from BrainStorm

Colorectal cancer study finds potential in overlooked immune cell

After a drawn out lobbying fight, ARPA

Liquid biopsy for lung cancer is launched by Delfi

Kaiser Permanente unions announce official strike date

leisure time

hotspot

knowledge

Wikipedia